Neurology 1111 - Neurology Alert - Nov 01, 2007

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Assistant Editors
John J. Caronna, MD
Vice-Chairman, Department of Neurology
Cornell University Medical Center
Professor of Clinical Neurology
NewYork-Presbyterian Hospital

Dara G. Jamieson, MD
Associate Professor of Clinical Neurology
Director, Headache Center
Weill Medical College of Cornell University

Michael Rubin, MD
Professor of Clinical Neurology
Weill Medical College of Cornell University
NewYork Presbyterian Hospital

Authors
Melissa J. Nirenberg, MD, PhD
ssistant Professor
Neurology and Neuroscience
Weill Cornell Medical College

Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience
Comprehensive Epilepsy Center
Weill Medical College of Cornell University

Erik J. Kobylarz, MD, PhD
Assistant Professor of Neurology and Neuroscience
Weill Cornell Medical College
Cornell University

Subjects:

  • Does Warfarin Benefit Offset Hemorrhage Risk in Elderly AF Patients?
  • Not Tonight, Dear! It May Cause a Headache
  • Predicting Respiratory Failure in Guillain-Barré Syndrome (GBS)
  • Driving and Parkinson's Disease
  • Can Continuous EEG Influence Outcome in Patients with Intracerebral Hemorrhage (ICH)?
  • Predictors of Visual Outcome After Acute Optic Neuritis

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Matthew Fink, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor John J. Caronna, MD reports no financial relationship relevant to this field of study. Assistant editor Dara G. Jamieson, MD is a consultant for Boehringer Ingelheim and Merck, and is on the speaker's bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer. Assistant editor Michael Rubin, MD is on the speaker's bureau for Athena Diagnostics, and does research for Pfizer and Merck. Author Melissa J. Nirenberg, MD, PhD participates in clinical research trials for Boehringer-Ingelheim. Authors Padmaja Kandula, MD, and Erik J. Kobylarz, MD, PhD report no financial relationships relevant to this field of study.

Copyright 2007 AHC Media. All rights reserved.